ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,449,000 | +318.1% | 49,096 | +210.8% | 0.03% | +233.3% |
| Q4 2020 | $2,021,000 | -78.1% | 15,797 | -80.8% | 0.01% | -75.0% |
| Q3 2020 | $9,239,000 | -12.0% | 82,104 | -25.5% | 0.04% | -32.1% |
| Q2 2020 | $10,503,000 | +2244.4% | 110,241 | +2111.0% | 0.05% | +1666.7% |
| Q1 2020 | $448,000 | -0.9% | 4,986 | -56.5% | 0.00% | +50.0% |
| Q3 2019 | $452,000 | +11.3% | 11,449 | +61.5% | 0.00% | +100.0% |
| Q3 2018 | $406,000 | – | 7,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |